AMIX
Autonomix Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$2.65
−6.85%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$2.73
From 52W high−89.03%
Volume36935.00
Market cap$5.19M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataOct 19, 2026
Open
$2.73
From 52W high
−89.03%
Volume
36935.00
Market cap
$5.19M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.1x
P/E (TTM)
—
RSI (14)
27.9
MomentumView details →
1D Return
−6.85%
YTD Return
−76.37%
SummaryUpdated Jun 1, 2026
Autonomix Medical, Inc. (NASDAQ:AMIX) is a development-stage medical device company founded in 2014 and based in The Woodlands, Texas. The company went public in January 2024 and focuses on developing innovative technologies for sensing and treating disorders related to the peripheral nervous system. As a pre-revenue company, Autonomix is currently in the research and development phase, working to advance its proprietary catheter-based sensing technology platform.
Similar companies
Latest newsMore news →
Autonomix Medical strengthened patent protection for its catheter-based platform technology enabling transvascular access, treatment guidance, adaptive treatment delivery, and real-time procedural validation beyond the lumen wall.18d agoAutonomix received positive FDA pre-submission feedback supporting a 510(k) Class II pathway for U.S. clearance of its standalone sensing platform, with potential initial clearance in approximately 15 months.20d agoAutonomix Medical, Inc. appointed Sandra Kalter as an independent member of its Board of Directors, effective September 14, 2026.34d ago